Imidazopiperazine inhibitors of transcription activating proteins
The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of transcription activating proteins such as CBP and P300 for the treatment or prevention of diseases such as proliferative diseases, inflammatory disorders, autoimmune diseases, and fibrotic disea...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CARROLL, Christopher L JONES, Philip MANDAL, Pijus K MCAFOOS, Timothy J CROSS, Jason LE, Kang SOTH, Michael J |
| description | The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of transcription activating proteins such as CBP and P300 for the treatment or prevention of diseases such as proliferative diseases, inflammatory disorders, autoimmune diseases, and fibrotic diseases. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2019245403A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2019245403A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2019245403A13</originalsourceid><addsrcrecordid>eNqNyj0KAkEMBtBtLES9w4C1sH8WloMo2mu9xDGrH2gSZoLFnt7GA1i95s2reH7jTpMajDNNEA6QJ25wzSXoGDyTlJRhDpVAyfEhhzyCZXWGlGU1G-lVePVzUa2Ph8v-tGHTgYtRYmEf4rWtm13bb_u6i0333_oCc3Ez1g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Imidazopiperazine inhibitors of transcription activating proteins</title><source>esp@cenet</source><creator>CARROLL, Christopher L ; JONES, Philip ; MANDAL, Pijus K ; MCAFOOS, Timothy J ; CROSS, Jason ; LE, Kang ; SOTH, Michael J</creator><creatorcontrib>CARROLL, Christopher L ; JONES, Philip ; MANDAL, Pijus K ; MCAFOOS, Timothy J ; CROSS, Jason ; LE, Kang ; SOTH, Michael J</creatorcontrib><description>The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of transcription activating proteins such as CBP and P300 for the treatment or prevention of diseases such as proliferative diseases, inflammatory disorders, autoimmune diseases, and fibrotic diseases.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201022&DB=EPODOC&CC=AU&NR=2019245403A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201022&DB=EPODOC&CC=AU&NR=2019245403A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CARROLL, Christopher L</creatorcontrib><creatorcontrib>JONES, Philip</creatorcontrib><creatorcontrib>MANDAL, Pijus K</creatorcontrib><creatorcontrib>MCAFOOS, Timothy J</creatorcontrib><creatorcontrib>CROSS, Jason</creatorcontrib><creatorcontrib>LE, Kang</creatorcontrib><creatorcontrib>SOTH, Michael J</creatorcontrib><title>Imidazopiperazine inhibitors of transcription activating proteins</title><description>The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of transcription activating proteins such as CBP and P300 for the treatment or prevention of diseases such as proliferative diseases, inflammatory disorders, autoimmune diseases, and fibrotic diseases.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyj0KAkEMBtBtLES9w4C1sH8WloMo2mu9xDGrH2gSZoLFnt7GA1i95s2reH7jTpMajDNNEA6QJ25wzSXoGDyTlJRhDpVAyfEhhzyCZXWGlGU1G-lVePVzUa2Ph8v-tGHTgYtRYmEf4rWtm13bb_u6i0333_oCc3Ez1g</recordid><startdate>20201022</startdate><enddate>20201022</enddate><creator>CARROLL, Christopher L</creator><creator>JONES, Philip</creator><creator>MANDAL, Pijus K</creator><creator>MCAFOOS, Timothy J</creator><creator>CROSS, Jason</creator><creator>LE, Kang</creator><creator>SOTH, Michael J</creator><scope>EVB</scope></search><sort><creationdate>20201022</creationdate><title>Imidazopiperazine inhibitors of transcription activating proteins</title><author>CARROLL, Christopher L ; JONES, Philip ; MANDAL, Pijus K ; MCAFOOS, Timothy J ; CROSS, Jason ; LE, Kang ; SOTH, Michael J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2019245403A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>CARROLL, Christopher L</creatorcontrib><creatorcontrib>JONES, Philip</creatorcontrib><creatorcontrib>MANDAL, Pijus K</creatorcontrib><creatorcontrib>MCAFOOS, Timothy J</creatorcontrib><creatorcontrib>CROSS, Jason</creatorcontrib><creatorcontrib>LE, Kang</creatorcontrib><creatorcontrib>SOTH, Michael J</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CARROLL, Christopher L</au><au>JONES, Philip</au><au>MANDAL, Pijus K</au><au>MCAFOOS, Timothy J</au><au>CROSS, Jason</au><au>LE, Kang</au><au>SOTH, Michael J</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Imidazopiperazine inhibitors of transcription activating proteins</title><date>2020-10-22</date><risdate>2020</risdate><abstract>The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of transcription activating proteins such as CBP and P300 for the treatment or prevention of diseases such as proliferative diseases, inflammatory disorders, autoimmune diseases, and fibrotic diseases.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2019245403A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Imidazopiperazine inhibitors of transcription activating proteins |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T00%3A00%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CARROLL,%20Christopher%20L&rft.date=2020-10-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2019245403A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |